IGE CH3 PEPTIDE VACCINE

The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, imm...

Full description

Saved in:
Bibliographic Details
Main Authors BROWN ALAN DANIEL, KJERRSTROM ANNE MARIA KRISTINA, CHAMPION BRIAN ROBERT, ROBERTS LEE RICHARD, JONES LYN HOWARD, CHRISTY CLARE, GERVAIS DAVID PAUL, WYATT DAVID MICHAEL, PRYDE DAVID CAMERON
Format Patent
LanguageEnglish
Korean
Published 19.08.2011
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Bibliography:Application Number: KR20117015895